Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × talquetamab × Clear all

Phase

Phase 2 14 Phase 1 7 Phase 3 3 Phase 1/2 2 Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1 Multiple Myeloma 1

Interventions

Metformin 45 Dexamethasone 44 Cyclophosphamide 36 Saline Solution 33 Cytarabine 32 Zoledronic Acid 27 Cisplatin 27 Bupivacaine 27 Sodium Chloride 26 Letrozole 26 Propofol 25 Docetaxel 25 Carboplatin 25 Methotrexate 24 Dexmedetomidine 24 Bevacizumab 24 Vincristine 23 Fentanyl 23 Fluorouracil 22 Capecitabine 21 Doxorubicin 20 Rituximab 19 Morphine 19 Acetaminophen 18 Prednisone 17 Paclitaxel 17 Oxaliplatin 17 Imiquimod 17 Drug Therapy 17 Radiotherapy 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07474961 2026-03-16

BLOOD-dose

Rigshospitalet, Denmark

Phase 4 Not yet recruiting

LymphoidPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡